天合光能(688599.SH):專利"一種雙輻照計推測直射輻照比例方法"榮獲第二十五屆中國專利銀獎
格隆匯6月8日丨天合光能(688599.SH)公佈,近日,國家知識產權局發佈了關於第二十五屆中國專利獎授獎的決定,天合光能股份有限公司(以下簡稱"公司")以專利"一種雙輻照計推測直射輻照比例方法"榮獲第二十五屆中國專利銀獎。具體情況如下:

本次獲獎專利創新的提出了晴天指數推演算法以及與之匹配的雙輻照計設計方案,並突破國外技術封鎖,實現百分等級精確識別天氣狀態,進而實時動態調整跟蹤角度,確保光伏組件最大發電量。本專利設計方案精度高、成本低,解決了光伏跟蹤系統在項目應用中判斷天氣狀態、優化跟蹤角度的難題,可廣泛應用於光伏跟蹤電站,有效提升光伏跟蹤系統發電量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.